1. Kang R，Chen R，Zhang Q，Hou W，et al.HMGB1 in health and disease.Mol Aspects Med，2014，40（C）：1-116.

2. Chen R，Hou W，Zhang Q，Kang R，Fan XG，Tang D.Emerging role of high-mobility group box 1（HMGB1）in liver diseases.Mol Med，2013，19：357-366.

3. Yamamoto Y，Yamamoto H.Therapeutic strategies for RAGE-mediated diseases.Nihon Yakurigaku Zasshi，2014，143（1）：10-13.

4. Rauvala H，Rouhiainen A.Physiological and pathophysiological outcomes of the interactions of HMGB1 with cell surface receptors.Biochim Biophys Acta，2010，1799（1-2）：164-170.

5. Orlova VV，Choi EY，Xie C，Chavakis E，et al.A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin.EMBO J，2007，26（4）：1129-1139.

6. Friggeri A，Yang Y，Banerjee S，Park YJ，Liu G，Abraham E. HMGB1 inhibits macrophage activity in efferocytosis through binding to the alphavbeta3-integrin.Am J Physiol Cell Physiol，2010，299（6）：C1267-1276.

7. Schiraldi M，Raucci A，Muñoz LM，Livoti E，Celona B，Venereau E，et al.HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4.J Exp Med，2012，209（3）：551-563.

8. Chen GY，Tang J，Zheng P，Liu Y.CD24 and Siglec-10 selectively repress tissue damage-induced immune responses.Science，2009，323（5922）：1722-1725.

9. Bouchon A，Facchetti F，Weigand MA，Colonna M.TREM-1 amplifies inflammation and is a crucial mediator of septic shock.Nature，2001，410（6832）：1103-1107.

10. Taniguchi N，Kawahara K，Yone K，Hashiguchi T，Yamakuchi M，et al.High mobility group box chromosomal protein 1 plays a role in the Pathogenesis of rheumatoid arthritis as a novelcytokine.Arthritis Rheum，2003，48（4）：971-981.

11. Andersson U，Wang H，Palmblad K，Aveberger AC，et al. High mobility group 1 Protein（HMG-1）Stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med，2000，192（4）：565-570.

12. Degryse B，Bonaldi T，Scaffidi P，Müller S，Resnati M，Sanvito F，Arrigoni G，Bianchi ME. The high mobility group （HMG）boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells.J Cell Biol，2001，152（6）：1197-1206.

13. Sappington PL，Yang R，Yang H，Tracey KJ，Delude RL，Fink MP.HMGB1 B box increases the permeability of Caco-2 Enterocytic monolayers and causes derangements in intestinal barrier function in mice. Gastroenterology，2002，123 （3）：790-802.

14. Fiuza C，Bustin M，Talwar S，Tropea M，Gerstenberger E，Shelhamer JH，Suffredini AF.Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood，2003，101（7）：2652-2660.

15. Park JS，Arcaroli J，Yum HK，Yang H，Wang H，Yang KY. Activation of gene expression in human neutrophils by high mobility group box 1 protein.Am J Physiol Cell Physiol，2003，284（4）：C870-879.

16. Liu G，Wang J，Park YJ，Tsuruta Y，Lorne EF，Zhao X，Abraham E.High Mobility Group Protein-1 Inhibits Phagocytosis of Apoptotic Neutrophils through Binding to Phosphatidylserine.J Immunol，2008，181（6）：4240-4246.

17. Hou C，Zhao H，Liu L，Li W，Zhou X，Lv Y，Shen X，Liang Z，Cai S，Zou F.High Mobility Group Protein B1（HMGB1）in Asthma：Comparison of Patients with Chronic Obstructive Pulmonary Disease and Healthy Controls.Mol Med，2011，17（7-8）：807-815.

18. Sukkar MB，Wood LG，Tooze M，Simpson JL，McDonald VM，Gibson PG，Wark PA. Soluble RAGE is deficient in neutrophilic asthma and COPD.Eur Respir J，2012，39（3）：721-729.

19. Shim EJ，Chun E，Lee HS，Bang BR，Kim TW，Cho SH，Min KU，Park HW. The role of high-mobility group box-1 （HMGB1）in the pathogenesis of asthma.Clin Exp Allergy，2012，42（6）：958-965.

20. Lee CC，Lai YT，Chang HT，Liao JW，Shyu WC，Li CY，Wang CN.Inhibition of high-mobility group box 1 in lung reduced airway inflammation and remodeling in a mouse model of chronic asthma. Biochem Pharmacol，2013，86 （7）：940-949.

21. Hou C，Kong J，Liang Y，Huang H，Wen H，Zheng X，Wu L，Chen Y.HMGB1 contributes to allergen-induced airway remodeling in a murine model of chronic asthma by modulating airway inflammation and activating lung fibroblasts.Cell Mol Immunol，2014.

22. Rowe SM，Jackson PL，Liu G，Hardison M，Livraghi A，Solomon GM，et al.Potential Role of High-Mobility Group Box 1 in Cystic Fibrosis Airway Disease.Am J Respir Crit Care Med，2008，178（8）：822-831.

23. Hamada N，Maeyama T，Kawaguchi T，Yoshimi M，et al.The role of high mobility group box1 in pulmonary fibrosis.Am J Respir Cell Mol Biol，2008，39（4）：440-447.

24. Entezari M，Weiss DJ，Sitapara R，Whittaker L，Wargo MJ，Li J，etc.Inhibition of High-Mobility Group Box 1 Protein （HMGB1）Enhances Bacterial Clearance and Protects against Pseudomonas Aeruginosa Pneumonia in Cystic Fibrosis.Mol Med，2012，18：477-485.

25. Hanford LE，Fattman CL，Shaefer LM，et al.Regulation of receptor for advanced glycation end products during bleomycin-induced lung injury. Am J Respir Cell Mol Biol，2003，29（3 Suppl）：S77-81.

26. Ramsgaard L，Englert JM，Tobolewski J，Tomai L，et al.The role of the receptor for advanced glycation end-products in a murine model of silicosis.PLoS One，2010，5（3）：e9604.

27. Queisser MA，Kouri FM，Königshoff M，et al.Loss of RAGE in Pulmonary Fibrosis：Molecular Relations to Functional Changes in Pulmonary Cell Types.Am J Respir Cell Mol Biol，2008，39（3）：337-345.

28. Englert JM，Hanford LE，Kaminski N，Tobolewski JM，Tan RJ.A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis.Am J Pathol，2008，172（3）：583-591.

29. He M，Kubo H，Ishizawa K，Hegab AE，Yamamoto Y，Yamamoto H，Yamaya M.The role of the receptor for advanced glycation end-products in lung fibrosis.Am J Physiol Lung Cell Mol Physiol，2007，293（6）：L1427-436.

30. Wang H1，Bloom O，Zhang M，Vishnubhakat JM，Ombrellino M，et al.HMG-1 as a late mediator of endotoxin lethality in mice.Science，1999，285（5425）：248-51.

31. Wang H，Yang H，Czura CJ，Sama AE，Tracey KJ.HMGB1 as a late mediator of lethal systemic inflammation.Am J Respir Crit Care Med，2001，164：1768-1773.

32. Fan J，Li Y，Levy RM，Fan JJ，Hackam DJ，Vodovotz Y，Yang H et al.Hemorrhagic shock induces NAD（P）H oxidase activation in neutrophils：role of HMGB1-TLR4 signaling.J Immunol，2007，178（10）：6573-6580.

33. Kao RL，Xu X，Xenocostas A，Parry N，Mele T，Martin CM，Rui T.Induction of acute lung inflammation in mice with hemorrhagic shock and resuscitation：role of HMGB1.J Immunol，2007，178（10）：6573-6580.

34. Sharma AK，LaPar DJ，Stone ML，Zhao Y，Kron IL，Laubach VE. Receptor for Advanced Glycation End Products （RAGE）on iNKT Cells Mediates Lung Ischemia-Reperfusion Injury.Am J Transplant，2013，13（9）：2255-2267.

35. Ueno H，Matsuda T，Hashimoto S，Amaya F，Kitamura Y，Tanaka M，et al.Contributions of High Mobility Group Box Protein In Experimental and Clinical Acute Lung Injury.Am J Respir Crit Care Med，2004，170（12）：1310-1316.

36. Ding N，Wang F，Xiao H，Xu L，She S.Mechanical Ventilation Enhances HMGB1 Expression in an LPS-Induced Lung Injury Model.PLoS One，2013，8（9）：e74633.

37. Ogawa EN，Ishizaka A，Tasaka S，Koh H，Ueno H，Amaya F，Ebina M，Yamada S，et al.Contribution of High-Mobility Group Box-1 to the Development of Ventilator-induced Lung Injury.Am J Respir Crit Care Med，2006，174（4）：400-407.

38. Patel VS，Sitapara RA，Gore A，Phan B，Sharma L，et al. High Mobility Group Box-1 Mediates Hyperoxia-Induced Impairment of Pseudomonas aeruginosa Clearance and Inflammatory Lung Injury in Mice.Am J Respir Cell Mol Biol，2013，48（3）：280-7.

39. Achouiti A，van der Meer AJ，Florquin S，Yang H，et al. High-mobility group box 1 and the receptor for Advanced glycation end products contribute to Lung injury during Staphylococcus aureus pneumonia. Am J Respir Cell Mol Biol，2013，48（3）：280-287.

40. Moser B，Megerle A，Bekos C，Janik S，Szerafin T，Birner P，et al.Local and Systemic RAGE Axis Changes in Pulmonary Hypertension：CTEPH and iPAH.Crit Care，2013，17 （6）：R296.

41. Sadamura-Takenaka Y，Ito T，Noma S，et al.HMGB1 Promotes the Development of Pulmonary Arterial Hypertension in Rats.PLoS One，2014，9（7）：e102482.

42. Musumeci D，Roviello GN，Montesarchio D.An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies. Pharmacol Ther，2014，141 （3）：347-357.